touchPODCAST

touchPODCAST

By touchpodcastScience
Download on the App Store

touchPODCAST episodes

  • MDT perspectives on established methods for managing DMD

    touchMDT for touchNEUROLOGY

    Listen to key experts from a multidisciplinary team discuss established treatments and the importance of the multidisciplinary team in the management of DMD.

    The multidisciplinary team:

    • Paediatrician: Dr Laura Kauffman, Weissbluth Pediatrics, Chicago, IL, USA
  • Geneticist: Dr Nadia Merchant, Children’s National Hospital, Washington, DC, USA
  • Neurologist: Prof. Nancy Kuntz, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
  • This touchPODCAST is for HCPs only. 

    This activity is funded by an unrestricted independent medical education grant from Sarepta Therapeutics. This activity is jointly provided by USF Health and touchIME.

    For further information visit our website: https://touchneurologyime.org/mdt-insights-on-modern-medical-management-in-patients-with-dmd/

    14 min
  • MDT perspectives on novel pharmacological and gene therapies for patients with DMD

    touchMDT for touchNEUROLOGY

    Listen to key experts from a multidisciplinary team discuss novel pharmacological and gene therapies that are available or emerging for the management of DMD.


    The multidisciplinary team:

    • Neurologist: Prof. Nancy Kuntz, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
  • Geneticist: Dr Nadia Merchant, Children’s National Hospital, Washington, DC, USA
  • This touchPODCAST is for HCPs only.


    This activity is funded by an unrestricted independent medical education grant from Sarepta Therapeutics. This activity is jointly provided by USF Health and touchIME.

    For further information visit our website: https://touchneurologyime.org/mdt-insights-on-modern-medical-management-in-patients-with-dmd/

    13 min
  • Understanding the pathophysiology of multiple sclerosis and the development of new therapies

    touchTALKS for touchIMMUNOLOGY

    Listen to a leading expert in the management of patients with multiple sclerosis review the cellular model of disease, and how disease pathophysiology can offer novel therapeutic targets. Prof. Derfuss outlines the role of immune cells in driving multiple sclerosis pathogenesis, explains how the pathobiology of the disease has driven the development of disease-modifying therapies, and reviews the mechanism of action and clinical trial landscape for Bruton’s tyrosine kinase inhibitors.

    The expert

    • Prof. Tobias Derfuss, University Hospital Basel, Switzerland

    This touchPODCAST is for HCPs only.

    This activity is funded by an independent medical education grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany.  This activity is jointly provided by USF Health and touchIME.

    For further information visit our website https://touchimmunologyime.org/pathophysiology_of_ms_and_development_of_treatments/

    32 min
  • Understanding the pathophysiology of multiple sclerosis and the development of new therapies

    touchTALKS for touchNEUROLOGY


    Listen to a leading expert in the management of patients with multiple sclerosis review the cellular model of disease, and how disease pathophysiology can offer novel therapeutic targets. Prof. Derfuss outlines the role of immune cells in driving multiple sclerosis pathogenesis, explains how the pathobiology of the disease has driven the development of disease-modifying therapies, and reviews the mechanism of action and clinical trial landscape for Bruton’s tyrosine kinase inhibitors.

    The expert

    • Prof. Tobias Derfuss, University Hospital Basel, Switzerland


    This touchPODCAST is for HCPs only.


    This activity is funded by an independent medical education grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany.  This activity is jointly provided by USF Health and touchIME.


    For further information visit our website https://touchneurologyime.org/pathophysiology_of_ms_and_development_of_treatments/   

    32 min
  • Emerging data with immunotherapy in ESCC and potential impact for clinical practice

    touchTALKS for touchONCOLOLOGY

    Listen to a leading expert discussing the recent developments in esophageal cancer with a primary focus on esophageal squamous cell carcinoma (ESCC) 

    The expert:

    • Dr Elizabeth Smyth, Addenbrooke’s Hospital, Cambridge, UK

    Overview:

    Part 1: Insights from 2021 (0:00)

    Part 2: Insights from ASCO and ESMO GI 2022 (13:29)
    Part 3: Insights from the updated ESMO Clinical Practice Guideline (24:08)
    Part 4: Insights from ESMO Asia 2022 and ASCO GI 2023 (34:53)

    This touchPODCAST is for HCPs only.

    Funding for this touchPODCAST is from an independent medical education grant from Novartis. This activity is provided by touchIME. 


    For further information please visit: https://touchoncologyime.org/congress-renal-cell-carcinoma-asco-gu-2023

    47 min
  • Improving the alpha-mannosidosis patient journey

    touchEXPERT OPINIONS for touchENDOCRINOLOGY

    Listen to a leading expert sharing insights on the natural history and prevalence of alpha-mannosidosis, how to establish diagnosis, and the current and emerging treatment options for patients with this lysosomal storage disorder. 

    The expert:

    • Prof. Barbara K Burton, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA

    This touchPODCAST is for HCPs only. 

    This activity is funded by an independent medical education grant from Chiesi USA, Inc. This activity is jointly provided by USF Health and touchIME. 

    For further information please visit: touchendocrinologyime.org/eo-on-improving-alpha-mannosidosis-patient-journey/

    36 min
  • Improving the alpha-mannosidosis patient journey

    touchEXPERT OPINIONS for touchRESPIRATORY

    Listen to a leading expert sharing insights on the natural history and prevalence of alpha-mannosidosis, how to establish diagnosis, and the current and emerging treatment options for patients with this lysosomal storage disorder. 

    The expert:

    • Prof. Barbara K Burton, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA

    This touchPODCAST is for HCPs only. 

    This activity is funded by an independent medical education grant from Chiesi USA, Inc. This activity is jointly provided by USF Health and touchIME. 

    For further information visit our website: www.touchrespiratoryime.org/eo-on-improving-alpha-mannosidosis-patient-journey/

    36 min
  • Improving the alpha-mannosidosis patient journey

    touchEXPERT OPINIONS for touchNEUROLOGY

    Listen to a leading expert sharing insights on the natural history and prevalence of alpha-mannosidosis, how to establish diagnosis, and the current and emerging treatment options for patients with this lysosomal storage disorder. 

    The expert:

    • Prof. Barbara K Burton, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA

    This touchPODCAST is for HCPs only. 

    This activity is funded by an independent medical education grant from Chiesi USA, Inc. This activity is jointly provided by USF Health and touchIME. 

    For further information visit our website: www.touchneurologyime.org/eo-on-improving-alpha-mannosidosis-patient-journey/

    36 min
  • HER2 testing in colorectal cancer

    touchMDT for touchONCOLOGY

     A medical oncologist and a pathologist discuss HER2 testing in patients with colorectal cancer, including when and how to test, and the interpretation of test results.

    The multidisciplinary team:

    • Medical oncologist: Prof. Andrea Sartore-Bianchi, Niguarda Cancer Center, Milan, Italy
  • Pathologist: Dr Evgeny Yakirevich, Rhode Island Hospital, Providence, RI, USA
  • This touchPODCAST is for HCPs only.

    This activity is funded by an independent medical education grant from Seagen Inc. This activity is jointly provided by USF Health and touchIME.

    For further information visit our website: https://touchoncologyime.org/mdt-perspectives-on-management-of-her2-crc/

    15 min
  • Managing treatment side effects in HER2-positive colorectal cancer

    touchMDT for touchONCOLOGY

    A medical oncologist, advanced practice nurse and patient advocate discuss possible side effects of colorectal cancer treatments and how they can be managed in the multidisciplinary team setting.

    The multidisciplinary team:

    • Medical oncologist: Dr Kristen Ciombor, Vanderbilt University Medical Center, Nashville, TN, USA
  • Advanced practice nurse: Dr Kelley Rone, Mayo Clinic, Phoenix, AZ, USA
  • Patient advocate: Mr Scott Wilson, Denver, CO, USA
  • This touchPODCAST is for HCPs only.

    This activity is funded by an independent medical education grant from Seagen Inc. This activity is jointly provided by USF Health and touchIME.

    For further information visit our website: https://touchoncologyime.org/mdt-perspectives-on-management-of-her2-crc/

    10 min

About touchPODCAST

From the publisher's feed

Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites.